LeMaitre Vascular Announces Changes to Its Executive Management Team
April 10 2008 - 4:21PM
PR Newswire (US)
BURLINGTON, Mass., April 10 /PRNewswire-FirstCall/ -- LeMaitre
Vascular, Inc. (NASDAQ:LMAT) today announced the departure of Kevin
D. Kelly, Senior Vice President, North American Sales, to pursue
other business opportunities and the appointment of Robert V.
Linden to Vice President, North American Sales. Mr. Linden has
approximately six years North American sales experience with
LeMaitre Vascular. He joined LeMaitre Vascular in July 2002 as a
Sales Representative and has served in positions of increasing
responsibility within the North American organization. Since
January 2008, he has served as Director of Sales for the Eastern
United States and Canada, supervising three of the company's five
North American sales regions. From 2005 through 2007, Mr. Linden
served as Regional Sales Manager. Prior to LeMaitre Vascular, Mr.
Linden served as a sales representative at several medical device
companies, including Vasca, Inc., Atrium Medical Corporation,
Active Medical, Inc., and DePuy Orthopedics, Inc. Mr. Linden holds
a B.A. in Marketing from The Pennsylvania State University.
LeMaitre Vascular Chairman and Chief Executive Officer George W.
LeMaitre stated, "We want to thank Kevin Kelly for his
contributions and we wish him the best. We are thrilled to promote
Rob Linden to the position of Vice President, North American Sales.
I have watched Rob succeed at our company in positions of
increasing responsibility over the past six years. We believe he
will build on this experience to provide effective leadership for
our North American sales organization." About LeMaitre Vascular
LeMaitre Vascular develops, manufactures, and markets medical
devices for the treatment of peripheral vascular disease. The
company's principal executive offices are located at 63 Second
Avenue, Burlington, Massachusetts 01803. Certain statements set
forth above that are not clearly historical in nature are
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Although the company
believes that such statements are based on reasonable assumptions
within the bounds of its knowledge, these forward-looking
statements are neither promises nor guarantees. The forward-looking
statements made in this release are made only as of the date
hereof, and the company disclaims any intention or responsibility
for updating predictions or expectations contained in this release.
DATASOURCE: LeMaitre Vascular, Inc. CONTACT: Aaron Grossman,
Investor Relations of LeMaitre Vascular, Inc., +1-781-221-2266 Web
site: http://www.lemaitre.com/
Copyright
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From Jul 2024 to Jul 2024
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From Jul 2023 to Jul 2024